Search Results - PHARMACOTHERAPY OF THE CNS AND GI SYSTEM

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy by Tomasz Guzel, Dagmara Mirowska-Guzel

    Published in Molecules (2022-03-01)
    “…The aim of the present article is to review the 5-HT receptors in the gastrointestinal (GI) tract to determine the role of serotonin in GI physiology and pathology, including known GI diseases and the role of serotonin in GI pharmacotherapy.…”
    Get full text
    Article


  2. 2

    Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity by Jennifer S. Miller, Henrietta S. Bada, Philip M. Westgate, Thitinart Sithisarn, Markos Leggas

    Published in Children (2024-02-01)
    “…However, certain central nervous system (CNS) and gastrointestinal (GI) signs showed sporadic increases in prevalence notable around two weeks of treatment, accounting for increases in Finnegan scores that guided pharmacotherapy. …”
    Get full text
    Article


  3. 3

    Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System by Christopher J. O’Connell, Ryan S. Brown, Taylor M. Peach, Owen D. Traubert, Hana C. Schwierling, Gabrielle A. Notorgiacomo, Matthew J. Robson

    Published in Brain Sciences (2024-01-01)
    Get full text
    Article


  4. 4

    Gestational Age Alters Assessment of Neonatal Abstinence Syndrome by Sasha Amiri, Jayasree Nair

    Published in Pediatric Reports (2022-01-01)
    “…A modified Finnegan scoring system was used based on three different symptom categories, including Central Nervous System (CNS), Gastrointestinal (GI) and Other. …”
    Get full text
    Article


Search Tools: